Different safety profiles of oral anticoagulants in very elderly non-valvular atrial fibrillation patients. A retrospective propensity score matched cohort study-Reference-Cited by-同舟云学术

Different safety profiles of oral anticoagulants in very elderly non-valvular atrial fibrillation patients. A retrospective propensity score matched cohort study

Published:2018-08 Issue: Volume:265 Page:103-107
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Zoppellaro Giacomo^ORCID,Zanella Luca^ORCID,Denas Gentian,Gennaro Nicola,Ferroni Eliana,Fedeli Ugo,Padayattil Jose Seena,Costa Giorgio,Corti Maria Chiara,Andretta Margherita,Pengo Vittorio

Funder

Veneto Region, Italy

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann. Intern. Med.,2007

2. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014

3. New oral anticoagulants in elderly patients;Barco;Best Pract. Res. Clin. Haematol.,2013

4. Oral anticoagulant therapy for older patients with atrial fibrillation: a review of current evidence;Bo;Eur. J. Intern. Med.,2017

5. Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: propensity score matched cohort study;Denas;Int. J. Cardiol.,2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.;International Journal of Cardiology;2024-01

2. Efficacy and safety of non‐vitamin K antagonist oral anticoagulants in patients (≥80 years of age) with atrial fibrillation: systematic review and meta‐analysis;Internal Medicine Journal;2023-06-20

3. New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond;Expert Opinion on Pharmacotherapy;2023-05-29

4. A drug utilization study of oral anticoagulants in five representative cities of China between 2015 and 2019;Journal of Clinical Pharmacy and Therapeutics;2021-09-30

5. Clinical history and gastrointestinal bleeding in patients taking oral anticoagulants;International Journal of Cardiology;2021-09